BRIEF-EMA Publishes Clinical Data Supporting Marketing Authorisation Of COVID-19 Treatment Paxlovid
European Medicines Agency:
* EMA: EMA PUBLISHED CLINICAL DATA SUPPORTING THE MARKETING AUTHORISATION OF COVID-19 TREATMENT PAXLOVID: 06/07/2022
European Medicines Agency:
* EMA: EMA PUBLISHED CLINICAL DATA SUPPORTING THE MARKETING AUTHORISATION OF COVID-19 TREATMENT PAXLOVID: 06/07/2022
Google News
RSS
Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.
By submitting, you agree that we may use your email address to respond.
